Creatinine is synthesized in the human body at the time of muscle contractions. The glomeruli of the kidney removes creatinine from the blood and secretes it into the urine. Creatinine test is a sensitive test employed for measuring the glomerular filtration rate of the kidney. Hence, the creatinine test is extensively used to assess kidney functioning. Presently, direct and automation-ready procedures are gaining popularity in the field of research and drug discovery for measuring creatinine concentration in biological samples. Hence, demand for measuring creatinine for diagnosing kidney diseases is increasing globally. Creatinine assay kits are designed to measure creatinine in biological samples without the need for any pretreatment. Major advances in the determination of creatinine levels contribute to the diagnosis of early-stage kidney diseases. Rise in demand for the detection of mycobacteria in the urine and increase in geriatric population suffering from kidney malfunctions are key factors that are projected to boost the demand for creatinine assays in the near future. However, new developments in analytical methods and urology diagnostic techniques are paving the way for early diagnosis and treatment of kidney diseases.
The serum creatinine test is routinely performed as a part of clinical chemistry across the globe. Expansion of the creatinine measurement market can be attributed to the rising incidence and prevalence of diabetes and kidney diseases, increase in research activities in the field of diagnostic research and surge in geriatric population. Rise in government initiative to raise awareness about renal disorders and their early diagnosis is anticipated to boost the global creatinine measurement market during the forecast period. Additionally, technological advancements and favorable reimbursements are expected to fuel the market during the forecasting period.
The creatinine measurement market can be segmented based on type, type of sample, product type, end-user, and region. In terms of type, the market can be bifurcated into enzymatic method and kinetic method. Based on type of sample, the market can be divided into urine and blood serum. In terms of product type, the market can be segregated into reagents and kits. Based on end-user, the creatinine measurement market can be categorized into hospital, diagnostic laboratories, and others.
In terms region, the global creatinine measurement market can be classified into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America and Europe are expected to account for large share of the market due to high awareness and adoption of testing in these regions. Asia Pacific is anticipated to be a lucrative region for the market. The market in the region is anticipated to expand at a considerable pace during the forecast period due to the rise in adoption of advanced diagnostic testing and expansion of health care infrastructure in countries such as India and China. Brazil is projected to account for a dominant share of the creatinine measurement market in Latin America during the forecast period.
The global creatinine measurement market is fragmented with the presence of many global and regional players operating across all regions. Key players operating in the global creatinine measurement market include Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers, Pointe Scientific, Inc., Randox Laboratories, Ortho Clnical Diagnostics, and Diazyme Laboratories, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]